22h
News Medical on MSNMedtronic receives FDA approval for BrainSense Adaptive DBS technologyFor the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
The brain-computer interface technology personalizes therapy based on an individual’s brain activity.
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results